Expression of the two closely linked gene products, C2 and factor B, after DNA-mediated gene transfer provides a system for further analysis of regulation in both normal and deficient states.
Introduction
Factor B, of the alternative complement-activating pathway, and C2, ofthe classical complement-activating pathway, have many structural and functional similarities (reviewed in reference 1). Synthesis of factor B and C2 occurs predominantly in the liver, but also in extrahepatic mononuclear phagocytes (2) . Factor B is synthesized as a single-chain '90-95,000-D glycoprotein. Receivedfor publication 19 December 1984. native pathway C3 converting enzyme. C2 is synthesized as a single-chain -92,000-D glycoprotein, which is also cleaved into a large carboxy terminal fragment (C2a) and a small, C2b fragment. The C2a fragment then combines with a cleavage product ofthe fourth component, C4b, to generate the classical pathway C3 convertase. Although C3 serves as substrate for both activation pathways, differences in local concentrations of the C2 and factor B proteins may effect the relative importance of the classical and alternative pathways in initiation ofthe complement effector system.
By genetic linkage analysis, the genes encoding these complement proteins have been mapped to the major histocompatibility complex (MHC)' on the short arm of chromosome 6 in humans and on chromosome 17 in mouse (reviewed in reference 3). Recently, cosmid cloning has demonstrated extremely close linkage ofthe human genes with the 3'-end of the C2 gene lying within -2,000 base pairs of the 5'-end ofthe factor B gene, and with the C4 genes lying an additional 10,000 base pairs further downstream (4, 5) . The gene order in the human class III region is, thus, C2, factor B, and two C4 genes. Although similar linkage of factor B and C4 genes has been shown in mouse (6) , the order of the murine C2 and factor B genes on chromosome 17 has not been previously determined.
Despite this extensive structural and functional similarity, and close linkage within the class III region of the MHC, there are major differences in the expression of factor B and C2 (7) (8) (9) (10) (11) . In fact, both species-specific and tissue-specific differences in the expression of these two complement proteins have been demonstrated. The present study uses DNA-mediated gene transfer to introduce the genes encoding both human and mouse C2 and factor B into L cells. With the genes from both man and mouse introduced into the same genetic background, it should be possible to investigate which features of the differential expression of these genes are characteristic of the genes themselves and which are the result of differential processing by the cells in which they are transcribed. In addition, transfected L cells might provide a system in which to examine, both at the transcriptional and translational level, the modulation of expression of these two early acting complement proteins by mediators of inflammation.
Methods
Materials. Dulbecco's modified essential medium (DME), DME lacking
Preparation and screening of cosmid libraries. The preparation of the murine cosmid genomic library (H-2d) and initial isolation ofclones has been described previously (6) . The murine cosmid cluster was extended using cosmid walking procedures as described (6) . The human cosmid genomic library was constructed from DNA isolated from the cell line JY, using methods similar to those used for the murine library except that the insert DNAs were size fractionated by sucrose gradient centrifugation before ligation to the cosmid vector pJB8. The human cosmid library was screened according to the method ofHanahan and Meselson (12) using as a probe the human cDNA insert of plasmid pBfA28 (13), 32P-labeled by nick-translation (14) . Cosmid DNA was isolated according to the method of Ish-Horowicz and Burke (15) .
Cell culture and biosynthetic labeling. Mouse L cells (TK-) and HepG2 cells were maintained as monolayers in 75-cm2 tissue culture flasks with DME containing 109% heat-inactivated fetal bovine serum as previously described (16, 17) . Mouse peritoneal macrophages were harvested and adhered to plastic tissue culture wells as previously described (7) . For biosynthetic labeling, cells were subcultured into 35-mm dishes, incubated in serum-free medium for 12 h, and rinsed three times with DME lacking methionine. L-[33S]methionine, 500 MCi/ml ofDME lacking methionine, was added and cells incubated at 37°C, 5% C02/95% air for time periods ranging from 30 min to 24 h (pulse period). At the end of the pulse period, unlabeled methionine-containing medium was then added in 200-1,000-fold excess for time periods up to 6 h (chase period). At specified intervals, culture medium was harvested and monolayers rinsed six times, solubilized in 1% Triton X-100, 0.5% deoxycholic acid, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, leupeptin, and pepstatin A, 100 Ag/ml each, in Dulbecco's phosphate-buffered saline (PBS), pH 7.6, and subjected to two freeze-thaw cycles. Supernatants and lysates were clarified by centrifugation at 15,000 g for 5 and 30 min, respectively, and stored at -70°C. Trichloroacetic acid-precipitable protein was determined as previously described (18) .
Immunoprecipitation and SDS-polyacrylamide gel electrophoresis (PAGE). For staphylococcal protein A immunoprecipitation, 100-300-Ml aliquots of cell lysate or medium were incubated overnight at 4°C in an equal volume of PBS containing 1% Triton X-100, 0.5% SDS, and 5 mg/ml bovine serum albumin, with aliquots of antiserum previously determined to precipitate all labeled antigen. Characteristics of the antiserum have been described (16) . Excess formalin-fixed staphylococci bearing protein A was added for 1 h at 4°C. Immunoprecipitates were washed, released by boiling in sample buffer, and applied to 7.5% SDS-PAGE under reducing conditions as described by Laemmli (19) . Mo DNA-mediated gene transfer. Gene transfer followed a previously described modification ofthe technique ofWigler et al. (17, 20) . Cosmid DNA (5 Mg), pBR-TK DNA (0.5-1.0 Mg), and C3H/HeJ liver DNA (20 Mg) were incorporated into a calcium phosphate precipitate and applied to 100-mm culture dishes containing 1-2 X 106 cells. Within 48 h, medium was replaced by a selective medium (DME containing 10% fetal bovine serum, 1.36 mg/ml hypoxanthine, 17.4 ,g/ml aminopterin, and 388 jug/ml thymidine [HAT]). HAT-resistant colonies were isolated and propagated in selective medium.
Southern and Northern blotting. High molecular weight DNA and total cellular RNA were isolated using previously described techniques (21, 22) . DNA was digested to completion with fourfold excess of restriction enzyme and fractionated by agarose gel electrophoresis. RNA was denatured by heating in formaldehyde and fractionated in agaroseformaldehyde electrophoresis before transfer to nitrocellulose, hybridization to the appropriate radiolabeled cDNA probe, and autoradiography (23) .
Assay ofC2 hemolytic activity. Reagents were prepared and hemolytic titration specifically for human C2 activity were conducted according to the method of Rapp and Borsos (24) .
Results
Cloning and chromosomal localization of the murine second component ofcomplement gene. Restriction endonuclease digestion of cosmid DNAs isolated from an H-2d murine genomic library (6) followed by Southern blot analysis using as a probe a cDNA encoding a portion of human C2 (pC2-6, reference 25) as well as a probe encoding a portion of murine C2 (kindly provided by Drs. P. Lapre and A. S. Whitehead, Children's Hospital), indicated that the gene encoding murine C2 was located 5' to the gene encoding murine factor B (Fig. 1) . Cosmid D-9 appeared to span both the C2 and factor B genes. Using 5 'and 3 ' subfragments of the human C2 cDNA as probes, it was possible to show that the murine C2 gene shares the same 5'-3' orientation as the murine factor B gene. Southern blot analysis of H-2d genomic DNA showed co-migrating Bam HI (6.9 kilobase (kb)), Hind III (4.7 kb), Kpn I (20 kb), and Sac I (14 kb) fragments using the murine C2 and human factor B cDNAs as probes (Fig. 2 ). These probes hybridized to different XbaI fragments (C2, 5.1 kb; factor B, 7.0 kb). An identical hybridization pattern was observed in Southern blots of cosmid D-9 using the same probes (data not shown). The C2 and factor B genes were separated by <4,500 base pairs. It was not possible to determine the exact distance between the two genes because a cDNA containing the 5' end of the murine factor B gene is not currently available. These data are similar to results obtained from studies of cosmids containing the human C2 and factor B genes (4).
Isolation ofcosmid clones containing genes encoding human C2 andfactor B. A human cosmid library was screened using a cDNA encoding human factor B (pBfA28, reference 13) as a probe. Two cosmids, designated cBf1 and cBf2 (Fig. 1) , were isolated, and contained factor B-hybridizing restriction fiagments that co-migrated with human genomic factor B restriction fragments on gel electrophoresis (data not shown). These cosmids also contained restriction fragments that hybridized with the human C2 cDNA (data not shown). Neither cosmid contained sequences homologous to a human C4 cDNA. In subsequent experiments, the cosmid DNA encoding the murine C2 and factor B genes, cosmid D-9, will be referred to as the murine cosmid, and the cosmid DNAs encoding the human C2 and factor B genes, cosmids cBfl and cBf2, will be referred to as the human cosmids. to 3' from the left of the figure to the right. The boundaries of the genes have not been determined precisely and are shown by wavy lines. The restriction map of the murine cosmids using BamH I and EcoRl, as previously described (6), is indicated. The exact extents of cosmids cBfl and cBf2 have not been determined and are indicated by dotted lines. The scale is in kb pairs.
DNA-mediated gene transfer. In order to examine the expression ofC2 and factor B, the murine cosmid and the human cosmid were co-transfected with the herpes simplex virus thymidine kinase gene into separate L cell monolayers, and transfectants were selected using HAT medium. More than 75% of HAT-resistant colonies contained cosmid DNA sequences. By Southern blot analysis, cosmid DNA sequences were present in HAT-resistant colonies in [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] copies per cell (data not shown).
Identification offactor B and C2 RNA in transfected cells. (Fig. 3) . Factor B RNA was not detected in mouse L cells transfected with the control plasmids (Fig. 3) . C2 mRNA was detected in untransfected L cells and L cells transfected with the control plasmid, appearing at~-2.6 kb on Northern blot analysis ( Fig. 3 ) and co-migrating with human liver, human bronchoalveolar macrophage (Fig. 4, lanes 1 and 2) (14) . Hybridization was as indicated with the 0.9-kb insert of pC2M I (lanes [1] [2] [3] [4] [5] and the 1.9-kb insert of pBfA28 (6) (7) (8) (9) (10) (6) and hybridized with the human C2 cDNA as described in Fig. 3 . The -2.6 kb C2 RNA is indicated. and "-89,000 D were detected in the intracellular contents, and two polypeptides of -90,000 and -92,000 D were secreted, co-migrating with factor B polypeptides synthesized and secreted by murine peritoneal macrophages (Fig. 5, lanes 3 and 4) . Cells transfected with the human cosmid synthesized factor B as a single polypeptide, -90,000 D in apparent size, and secreted a single -92,000-D factor B polypeptide (Fig. 5, lanes 5 and 6) . Single factor B polypeptides of the same apparent size were also synthesized and secreted by human hepatoma-derived hepatocytes (Fig. 5, lanes 7 and 8) . There was no evidence for synthesis and secretion of factor B by mouse L cells transfected with the control plasmid (Fig. 5, lanes 9 and 10) .
The kinetics of synthesis and secretion of factor B by L cells transfected with the human cosmid (Fig. 6 A) were compared with those of L cells transfected with the murine cosmid (Fig. 6  B) in pulse-chase experiments. The single, -90,000-D intracellular factor B polypeptide synthesized by L cells transfected with the human cosmid began to disappear at 30-60 min of the chase period, coincident with its appearance in the fully glycosylated -92,000 D form in the intra-and extracellular contents (Fig. 6 A) . Factor B is secreted with similar kinetics over the remaining 360 min of the chase period. Two intracellular factor B polypeptides are synthesized by L cells transfected with the murine cosmid (Fig. 6 B) . Kinetics of synthesis and secretion of these two polypeptides were similar to those of the single polypeptide in L cells transfected with the human cosmid.
Synthesis and secretion of C2 was detected in mouse L cells transfected with the control plasmids as well as in L cells trans- fected with the human and iutrine cosmids (Fig. 7) . The principle intracellular form of C2 was 86,000 mol wt, with additional faster migrating C2 polypeptides at 84,000, 70,000, 67,000, and 65,000 D similar to the additional lower molecular weight cellassociated forms of C2 protein observed in human hepatomaderived hepatocytes (Fig. 7, lanes 7 and 8, reference 16 ). C2 was secreted by L cells transfected with the human and murine cosmid and control plasmids as a polypeptide with apparent size of 94,000 D (Fig. 7, lanes 2, 4, and 6 ). Another -70,000 D form of C2 protein was also seen in the extracellular compartment and thought to be the C2a fragment. All the C2 polypep- (Fig. 8) . Culture fluid from L cells transfected with the murine cosmid or control plasmid (Fig. 8) or culture fluid from murine peritoneal macrophages in primary culture (data not shown) did not produce hemolysis in this assay.
Discussion
Structural and functional similarities between factor B and C2 have been attributed to primary sequence homology and have suggested evolution by gene duplication. In fact, recent molecular maps have indicated that the human factor B and C2 genes are less than -2,000 base pairs apart in the genome of the Class III region of the MHIC (4, 5) . Nevertheless, failure to demonstrate cross-hybridization of the two genes, even at very low stringency, indicates a substantial degree of nucleotide sequence divergence (26) . In addition to the nucleotide sequence differences implied by the cross-hybridization experiments, differences in the regulation of C2 and factor B by hepatocytes and mononuclear phagocytes from several species have also been identified (7) (8) (9) (10) (11) 16) .
In this study, we have demonstrated that the murine genes encoding C2 and factor B are very closely linked within the class III region of the murine MHC, with organization similar to that in man. Expression of human and murine factor B and human C2 was demonstrated in a murine fibroblast cell line transfected with cosmid DNA containing these genes. Factor B RNA was detected in cells transfected with the human and murine cosmid but not in cells transfected with the control plasmid. Biosynthesis and secretion of factor B was detected in cells transfected with the human and murine cosmids by incorporation of a radiolabeled amino acid precursor into newly synthesized protein. Expression ofthe transferred human C2 gene was demonstrated by a distinct 2.0-kb C2 RNA species (Figs. 3 and 4) and functional activity of the transfected cell culture fluid in the human C2 hemolytic assay (Fig. 8) . L cells transfected with the murine cosmid contained higher steady state levels of C2 RNA than those transfected with the control plasmid; however, expression of the transferred murine C2 gene could not be further distinguished from endogenous C2 expressed in the control transfected cells because of the absence of polymorphic differences in C2 between the donor H-2d mice and the recipient H-2k L cells. After transfection of the human factor B and C2 genes into L cells on the same cosmid, both genes were expressed. Whereas factor B was synthesized, processed, and secreted with extraordinary fidelity, C2 was transcribed, or the transcript modified, in an altered form as seen in Northern blot analysis (Figs. 3 and  4) . The nature of the differences between the 2.0-kb C2 hybridizing sequences recovered from cells transfected with the human cosmid and the usual 2.6-kb C2 mRNA obtained from human and murine hepatocytes and macrophages is not known. Differences in the 2.0-kb RNA could reside in the untranslated region. It is also possible that this apparently smaller RNA encodes C2 in an alternative polypeptiJe form, which is similar to the previously reported cell associated forms of C2 (16) .
Differences in the expression of other closely linked genes has also been demonstrated before and after DNA-mediated gene transfer. Transcription of an alpha globin gene was different from that of a beta globin gene despite transfer into mouse erythroleukemia cells on the same plasmid (29) . In that case, regulation of expression was attributed to sequences within the individual structural genes. Further studies with cosmid DNAs containing the C2 and factor B genes individually will be necessary to localize sequences regulating the expression of C2 and factor B in transfected L cells. It is still possible that a single promoter on the 5' side of the C2 gene, individual promoters on the 5' sides ofthe C2 and factor B genes, or structural elements control the expression of C2 and factor B.
Several additional features of C2 and factor B expression have been identified in these experiments. Although not identical, multiple intracellular forms of C2 protein in transfected L cells are similar to multiple forms of C2 synthesized by human liver (16) . The multiple intracellular forms ofC2 identified in human liver have different fates, one form being secreted and two forms remaining cell associated. These forms are derived from distinct primary translation products and presumably distinct RNA species, as there is only a single C2 gene (16) . With these considerations in mind, further studies ofthe relationship between the additional distinct C2 RNA and the multiple intracellular forms of C2 in L cells transfected with the human cosmid DNA will be important. An interspecies variation between murine and human factor B was also identified. Factor B was synthesized and secreted as two polypeptides by L cells transfected with the murine cosmid, but as a single polypeptide by L cells transfected with the human cosmid. This difference was also observed for biosynthesis of factor B by murine cells (peritoneal macrophages) (30) in primary culture compared with that of human cells (hepatoma-derived hepatocytes). Since this variation in the way factor B is translated and processed is preserved when murine and human factor B genes are expressed in the same cell, the variation must reside in the factor B genes themselves, rather than in differential processing in the human or murine cells.
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These experiments, therefore, indicate that C2 and factor B are expressed by mouse L cells after DNA-mediated gene transfer, and that intracellular processing of these complement proteins is reproduced with extraordinary fidelity by the L cells. Further analysis of C2 and factor B in this system in comparison with human and murine hepatocytes and macrophages will allow a greater understanding oftheir differential regulation, both at the level of RNA metabolism and at the level of posttranslational processing and secretion.
